These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9356819)

  • 41. [Tetany caused by foscarnet in a female patient with acquired immunodeficiency syndrome].
    Vela Moreno J; Pascual Catalán A; Ramos Paesa C; Arazo Garcés P; Aguirre Errasti JM
    An Med Interna; 1995 Jul; 12(7):358-9. PubMed ID: 7578826
    [No Abstract]   [Full Text] [Related]  

  • 42. [Hypocalcemia and hypomagnesemia associated with the treatment with pentamidine in 2 patients with HIV infection].
    Cortés E; Jufresa J; Falcó V; Ribera E
    Med Clin (Barc); 1996 May; 106(18):717. PubMed ID: 8801377
    [No Abstract]   [Full Text] [Related]  

  • 43. Foscarnet.
    Med Lett Drugs Ther; 1992 Jan; 34(861):3-4. PubMed ID: 1309469
    [No Abstract]   [Full Text] [Related]  

  • 44. Fixed drug eruption due to foscarnet.
    Connolly GM; Gazzard BG; Hawkins DA
    Genitourin Med; 1990 Apr; 66(2):97-8. PubMed ID: 2160425
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Foscarnet and extended survival in AIDS patients.
    Am Fam Physician; 1991 Dec; 44(6):2244. PubMed ID: 1836090
    [No Abstract]   [Full Text] [Related]  

  • 46. [Regressive diffuse leukoencephalitis under foscarnet in an AIDS infected patient].
    Nicoli F; Dhiver C; Chave B; Poizot-Martin I; Gastaut JA; Gastaut JL
    Presse Med; 1992 Mar; 21(9):436. PubMed ID: 1314379
    [No Abstract]   [Full Text] [Related]  

  • 47. Acute dystonic reaction associated with foscarnet administration.
    Dubow JS; Panush SR; Rezak M; Leikin J
    Am J Ther; 2008; 15(2):184-6. PubMed ID: 18356641
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Foscarnet treatment in various cytomegalovirus infections.
    Brockmeyer NH; Hengge UR; Mertins L; Malessa R; Steinmetz R; Gooss M
    Int J Clin Pharmacol Ther Toxicol; 1993 Apr; 31(4):204-7. PubMed ID: 8388868
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Foscarnet versus ganciclovir in the management of cytomegalovirus disease in patients with AIDS.
    Minor JR
    Am J Hosp Pharm; 1991 Nov; 48(11):2478-9. PubMed ID: 1660675
    [No Abstract]   [Full Text] [Related]  

  • 50. Foscarnet: a possible cause of ulnar artery thrombosis in a patient with AIDS.
    Calligaro KD; Stern J; DeLaurentis DA
    J Vasc Surg; 1994 Dec; 20(6):1007-8. PubMed ID: 7990178
    [No Abstract]   [Full Text] [Related]  

  • 51. Neurologic sequelae associated with foscarnet therapy.
    Lor E; Liu YQ
    Ann Pharmacother; 1994 Sep; 28(9):1035-7. PubMed ID: 7803878
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Penile ulcerations with foscarnet.
    Lancet; 1990 Mar; 335(8688):547-8. PubMed ID: 1968562
    [No Abstract]   [Full Text] [Related]  

  • 53. [Importance of Foscarnet in the treatment of cytomegalovirus pneumopathy in a patient with acquired immunodeficiency syndrome].
    Brochard L; Salmeron S; Herve P; Petitpretz P; Boissonnas A; Simonneau G; Duroux P
    Presse Med; 1986 Nov; 15(40):2022-3. PubMed ID: 3025830
    [No Abstract]   [Full Text] [Related]  

  • 54. Treatment of CMV retinitis.
    Deray G; Katlama C; Jacobs C
    N Engl J Med; 1992 Jun; 326(25):1702. PubMed ID: 1317011
    [No Abstract]   [Full Text] [Related]  

  • 55. Foscarnet-induced severe hypomagnesemia and other electrolyte disorders.
    Gearhart MO; Sorg TB
    Ann Pharmacother; 1993 Mar; 27(3):285-9. PubMed ID: 8384030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
    Jabs DA
    Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Foscarnet therapy for AIDS-related opportunistic herpesvirus infections.
    Jacobson MA
    AIDS Clin Rev; 1992; ():173-89. PubMed ID: 1318736
    [No Abstract]   [Full Text] [Related]  

  • 58. Nephrotoxicity of antiviral therapies.
    Becker BN; Schulman G
    Curr Opin Nephrol Hypertens; 1996 Jul; 5(4):375-9. PubMed ID: 8823538
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis.
    ;
    N Engl J Med; 1992 Jan; 326(4):213-20. PubMed ID: 1345799
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome].
    Nagata Y; Fujino Y; Ono A; Mochizuki M; Mouri H; Oka S; Kimura S; Shimada K
    Nippon Ganka Gakkai Zasshi; 1994 Jul; 98(7):710-5. PubMed ID: 8067306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.